
        <!DOCTYPE html>
        <html>
        <head>
            <title>Biogen Inc. (BIIB) - Articles</title>
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <style>
                :root {
                    --primary-color: #000000;
                    --secondary-color: #666666;
                    --accent-color: #d5001c;
                    --text-color: #2c3e50;
                    --border-color: #e0e0e0;
                    --hover-color: #f8f9fa;
                }
                
                body { 
                    font-family: "Porsche Next", "Segoe UI", Arial, sans-serif;
                    margin: 0;
                    padding: 0;
                    color: var(--text-color);
                    background-color: #f5f6fa;
                    line-height: 1.6;
                }
                
                .header {
                    background: linear-gradient(135deg, #000 0%, #1a1a1a 100%);
                    padding: 25px 0;
                    box-shadow: 0 2px 10px rgba(0,0,0,0.2);
                    position: sticky;
                    top: 0;
                    z-index: 1000;
                    backdrop-filter: blur(10px);
                }
                
                .header::before {
                    content: '';
                    position: absolute;
                    top: 0;
                    left: 0;
                    right: 0;
                    bottom: 0;
                    background: radial-gradient(circle at 30% 50%, rgba(255,255,255,0.08) 0%, rgba(255,255,255,0) 70%);
                    pointer-events: none;
                }
                
                .header-content {
                    max-width: 1400px;
                    margin: 0 auto;
                    padding: 0 30px;
                    display: flex;
                    justify-content: space-between;
                    align-items: center;
                }
                
                .header-title {
                    font-size: 28px;
                    font-weight: 300;
                    color: #fff;
                    margin: 0;
                    letter-spacing: 1px;
                }
                
                .back-btn {
                    background: rgba(255,255,255,0.1);
                    border: 1px solid rgba(255,255,255,0.2);
                    padding: 10px 20px;
                    color: #fff;
                    text-decoration: none;
                    font-size: 14px;
                    border-radius: 4px;
                    transition: all 0.3s ease;
                    backdrop-filter: blur(5px);
                }
                
                .back-btn:hover {
                    background: rgba(255,255,255,0.2);
                    transform: translateY(-2px);
                }
                
                .container {
                    max-width: 1400px;
                    margin: 40px auto;
                    padding: 0 30px;
                }
                
                .stats-container {
                    display: grid;
                    grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
                    gap: 20px;
                    margin-bottom: 40px;
                }
                
                .stat-card {
                    background: #fff;
                    border-radius: 12px;
                    padding: 25px;
                    text-align: center;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: transform 0.3s ease;
                }
                
                .stat-card:hover {
                    transform: translateY(-5px);
                }
                
                .stat-value {
                    font-size: 32px;
                    font-weight: 300;
                    color: var(--primary-color);
                    margin-bottom: 10px;
                }
                
                .stat-label {
                    font-size: 14px;
                    color: var(--secondary-color);
                    text-transform: uppercase;
                    letter-spacing: 1px;
                }
                
                .articles-grid {
                    display: grid;
                    grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
                    gap: 30px;
                    margin-top: 40px;
                }
                
                .article-card {
                    background: #fff;
                    border-radius: 12px;
                    overflow: hidden;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: all 0.3s ease;
                }
                
                .article-card:hover {
                    transform: translateY(-5px);
                }
                
                .article-content {
                    padding: 25px;
                }
                
                .article-title {
                    font-size: 18px;
                    font-weight: 400;
                    margin: 0 0 15px;
                    line-height: 1.4;
                }
                
                .article-title a {
                    color: var(--primary-color);
                    text-decoration: none;
                    transition: color 0.2s ease;
                }
                
                .article-title a:hover {
                    color: var(--accent-color);
                }
                
                .article-meta {
                    display: flex;
                    align-items: center;
                    gap: 20px;
                    margin-bottom: 15px;
                    font-size: 14px;
                    color: var(--secondary-color);
                }
                
                .article-sentiment {
                    padding: 4px 12px;
                    border-radius: 20px;
                    font-weight: 500;
                    font-size: 14px;
                }
                
                .article-sentiment.positive {
                    background: rgba(40,167,69,0.1);
                    color: #28a745;
                }
                
                .article-sentiment.negative {
                    background: rgba(220,53,69,0.1);
                    color: #dc3545;
                }
                
                .article-sentiment.neutral {
                    background: rgba(108,117,125,0.1);
                    color: #6c757d;
                }
                
                .article-summary {
                    font-size: 14px;
                    color: var(--text-color);
                    line-height: 1.6;
                    margin-top: 15px;
                    opacity: 0.8;
                }
                
                @media (max-width: 768px) {
                    .header-content {
                        padding: 0 20px;
                    }
                    
                    .header-title {
                        font-size: 20px;
                    }
                    
                    .container {
                        padding: 0 20px;
                        margin: 20px auto;
                    }
                    
                    .articles-grid {
                        grid-template-columns: 1fr;
                        gap: 20px;
                    }
                    
                    .stat-card {
                        padding: 20px;
                    }
                    
                    .stat-value {
                        font-size: 28px;
                    }
                }
            </style>
        </head>
        <body>
            <div class="header">
                <div class="header-content">
                    <h1 class="header-title">Biogen Inc. (BIIB)</h1>
                    <a href="sentiment_report_latest.html" class="back-btn">← Back to Dashboard</a>
                </div>
            </div>
            
            <div class="container">
                <div class="stats-container">
                    <div class="stat-card">
                        <div class="stat-value">64</div>
                        <div class="stat-label">Total Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">38</div>
                        <div class="stat-label">Positive Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">9</div>
                        <div class="stat-label">Negative Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">0.32</div>
                        <div class="stat-label">Average Sentiment</div>
                    </div>
                </div>
                
                <div class="articles-grid">
        
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=57255d980f4da737750a4c15fff79c3d38b351ed8ad171479891927207455058" target="_blank" rel="noopener noreferrer">We Think Biogen's (NASDAQ:BIIB) Profit Is Only A Baseline For What They Can Achieve</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-07</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NasdaqGS:BIIB 1 Year Share Price vs Fair Value Explore Biogen's Fair Values from the Community and select yours Biogen......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=6dde105958fe560ebdb5c8e3d41004d62882fe8e2a662ef3af62754c7884e26e" target="_blank" rel="noopener noreferrer">Eli Lilly And Biogen (And Eisai): Muddying The Waters In Alzheimer's Disease</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-07</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">nan...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=02c4ed87efd185f9b4e51a47ad20af803a28f017f9ab4a07c8d8a2bbb3cc1991" target="_blank" rel="noopener noreferrer">Biogen Inc. (BIIB): A Bull Case Theory</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-04</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">We came across a bullish thesis on Biogen Inc. on r/Valueinvesting subreddit by U/Lobyous. In this article, we will summarize the bulls’ thesis on BIIB. Biogen Inc.’s share was trading at $131.52 as o...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=6652e78474b5c4bf59d987303e5ca8a2962d636cb97dc23ed02e63a29b4bd9b4" target="_blank" rel="noopener noreferrer">Acadia Pharmaceuticals Appoints Scott Cenci as Chief Information and Data Officer</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-04</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">SAN DIEGO, August 04, 2025--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Scott Cenci as Senior Vice President, Chief Information and Data Officer. In this role, Scott ...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=ca1ca338388e431a12925359838a668c3b60c334427fd7044161c76aafdda6b7" target="_blank" rel="noopener noreferrer">Biogen: Strong Q2 Doesn't Change The Math On Eroding MS Portfolio</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-02</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment negative">
                                    -0.48
                                </span>
                            </div>
                            <div class="article-summary">Biogen beat Q2 estimates with cost control and new launches, but MS declines and pipeline risks cloud growth. Find out why BIIB stock is a hold....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f21d6b76388dc374b39417d55c8f119e1fd193d9ed2417f2a2a838ada6fdb9d6" target="_blank" rel="noopener noreferrer">Results: Biogen Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.92
                                </span>
                            </div>
                            <div class="article-summary">A week ago, Biogen Inc. ( NASDAQ:BIIB ) came out with a strong set of quarterly numbers that could potentially lead to......</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=25dd9c096cf792ce59ec238cbdaeeeb67cc7cdb50ac4be25ccd60fd34d09568b" target="_blank" rel="noopener noreferrer">Merck & Co. assembles an Alzheimer’s comeback with a next-gen precision focus</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-01</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.44
                                </span>
                            </div>
                            <div class="article-summary">With two molecules in mid-stage trials, the pharma giant is taking another swing at the difficult disease with a greater understanding of its drivers....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d6a8a126ed634ce3a96fcf1bec40ef58a0fa3c2ef4829016e253ba53f5122e04" target="_blank" rel="noopener noreferrer">Supernus strengthens neuropsychiatric portfolio with Sage Therapeutics</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-01</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.89
                                </span>
                            </div>
                            <div class="article-summary">The addition of Zurzuvae is expected to diversify and increase the company's revenue base and cash flow....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b6ab9cbe247e43536b500d992a8c39b937fd7e4ee56077f59e321a55f231d03c" target="_blank" rel="noopener noreferrer">Regeneron cancer bispecific rejected again; Allogene discloses trial death</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-01</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.56
                                </span>
                            </div>
                            <div class="article-summary">The FDA issued a complete response letter for Regeneron's lymphoma drug odronextamab. Elsewhere, Bristol Myers raised its guidance and analysts saw progress in Biogen’s turnaround....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a31960e48931f8e5b447ac47d7f00e98d569eeeec6a7901daeadd5391f9b5dca" target="_blank" rel="noopener noreferrer">Biogen Inc. stock outperforms competitors on strong trading day</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-01</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment positive">
                                    0.94
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock outperforms competitors on strong trading day...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=abcf80af83ca755a07b5846c255af1d8bdf93f5382842bb846c2c57dd4834969" target="_blank" rel="noopener noreferrer">Biogen Raises 2025 Outlook After Momentum in 1H</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-31</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment positive">
                                    0.79
                                </span>
                            </div>
                            <div class="article-summary">Biogen Raises 2025 Outlook After Momentum in 1H...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f304a180423e033b5a2b7661e14cdb110733c435dcaf9533a22205491e1b0c7e" target="_blank" rel="noopener noreferrer">Multiple Sclerosis Clinical Trials Market Landscape Report 2025 Featuring Biogen, Novartis, Sanofi, Merck, Teva, Bayer, Roche, Bristol-Myers Squibb, Laboratory Corp of America, IQVIA</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-31</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Discover key insights with the "Multiple Sclerosis - Global Clinical Trials Review, 2025" report. Gain an overview of global MS clinical trial landscapes, including data by region, phase, and sponsor....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=efee561e2b12f55c5ea0003229f3ded7909dc72f26be827225e719dc70e2e494" target="_blank" rel="noopener noreferrer">Biogen raises annual profit forecast on strong demand for rare disease drugs</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-31</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.94
                                </span>
                            </div>
                            <div class="article-summary">Its shares rose 5.4% in premarket trading, with the company also topping sales estimates for its keenly-watched Alzheimer's treatment Leqembi, which has struggled with slower uptake.  Meanwhile, Bioge...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=7b75af14bdd466bdb24c0ca7b0b8fa2674a87e179f91673b3c2c0636537e71de" target="_blank" rel="noopener noreferrer">Sales of Leqembi® totaled 23.1 billion yen in the second quarter 2025</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-31</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.56
                                </span>
                            </div>
                            <div class="article-summary">BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today published the preliminary global revenue for Leqembi during the second quarter 2025, in conjunction with their partner Biogen's sec...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f18520da70879589b802b7b5b1c42c6c48b98fa3a55d78a5a145c60a9a3ecb5b" target="_blank" rel="noopener noreferrer">Biogen lifts full-year outlook amid Alzheimer’s drug strength, sending shares up</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-31</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.86
                                </span>
                            </div>
                            <div class="article-summary">Investing.com - Shares of Biogen (NASDAQ:BIIB) rose in premarket U.S. trading on Thursday after the drugmaker posted better-than-anticipated first-quarter revenue and raised its full-year guidance tha...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=cab8c2b2225dd066a2724ffab3547f39f22d10971e9c172f6c823cf565185903" target="_blank" rel="noopener noreferrer">Biogen Inc. (BIIB) Surpasses Q2 Earnings and Revenue Estimates</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-31</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.38
                                </span>
                            </div>
                            <div class="article-summary">Biogen (BIIB) delivered earnings and revenue surprises of +39.19% and +13.89%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=fe71c921775fd63ea133f96a126f6c8b99317eb4128d39ba458034a408f3ae03" target="_blank" rel="noopener noreferrer">Biogen (NASDAQ:BIIB) Reports Bullish Q2</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-31</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.83
                                </span>
                            </div>
                            <div class="article-summary">Biotech company Biogen (NASDAQ:BIIB) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.3% year on year to $2.65 billion. Its non-GAAP profit of $5.47 per share was 41.3% above anal...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=05b5a71e55451490848d9aa36c213672fea9bbed6dc0f871127939ee3814afc3" target="_blank" rel="noopener noreferrer">Biogen Inc. 2025 Q2 - Results - Earnings Call Presentation</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-31</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">nan...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e732b152c6b10b4fca608183e877a8ad9b44b6899a22f56601054a16c2035684" target="_blank" rel="noopener noreferrer">Ionis Beats on Q2 Earnings & Sales, Stock Up 5% on Raised '25 Outlook</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-31</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.95
                                </span>
                            </div>
                            <div class="article-summary">Ionis crushes Q2 estimates with EPS of $0.86 and sales of $452 million, lifting its 2025 revenue forecast and sending shares up 5%....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=655744cf38e515c8955b7f1d7162e657e55d1e382984b71279a93c698c9353fb" target="_blank" rel="noopener noreferrer">Biogen (BIIB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-31</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Although the revenue and EPS for Biogen (BIIB) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street es...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=deaf8798f892727f0cec9d8041a6661e28cc2dfb096de433785d1a58134e2df4" target="_blank" rel="noopener noreferrer">Biogen Inc. (BIIB) Q2 2025 Earnings Call Transcript</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-31</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. (NASDAQ:BIIB) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ETCompany ParticipantsAlisha A....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a7bfda5b6979f20daad35b336b5ef8b78eec49065a494f0181eefef911334bc0" target="_blank" rel="noopener noreferrer">Biogen's Q2 Earnings & Sales Beat, 2025 Outlook Raised, Stock Up</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-31</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.95
                                </span>
                            </div>
                            <div class="article-summary">BIIB posts Q2 earnings and sales beat, lifts 2025 outlook on new drug growth and displays resilient MS performance....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=eb61b4a4732c6fd2d642d2884db3f704a58df676a7d65f2d12a6d29ca88a053e" target="_blank" rel="noopener noreferrer">Biogen Lifts Outlook As Rare Disease And Alzheimer's Drug Sales Accelerate</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-31</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.33
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. (NASDAQ:BIIB) reported on Thursday that the second quarter of 2025 adjusted earnings per share were $5.47, up 4% year over year, beating the analyst consensus of $4.06. The company reporte...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=2fe3b083c252de9b526ead7cadb297e31fd0b1a382c5e550e4c760f9d1eb5552" target="_blank" rel="noopener noreferrer">Biogen Earnings: What To Look For From BIIB</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-30</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Biotech company Biogen (NASDAQ:BIIB) will be reporting results this Thursday morning. Here’s what you need to know....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=012aa4ed868c1c7e047e64764fd3f20c7b42cabe04677cda546a6c7eb053b1bb" target="_blank" rel="noopener noreferrer">Eli Lilly eyes SoC status as Jaypirca proves superior to Imbruvica in CLL/SLL</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-30</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.95
                                </span>
                            </div>
                            <div class="article-summary">Jaypirca met its non-inferiority primary endpoint, trumping Imbruvica in patient overall response rate (ORR)....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=cb0b602093679f8a86cc18df99bb38d99b94f162671f2f79ef7a97c6bcc66129" target="_blank" rel="noopener noreferrer">Early Alzheimer's Patients Continue to Benefit from Four Years of LEQEMBI® (lecanemab-irmb) Therapy New Clinical Data Presented at AAIC</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-30</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.34
                                </span>
                            </div>
                            <div class="article-summary">Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced today that t...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=cc61adf01df02de7623c2e0bfba4953297c5591ff2ff11c4185f87dca8b1d807" target="_blank" rel="noopener noreferrer">New Data Presented at AAIC Demonstrates Investigational LEQEMBI® (lecanemab-irmb) 360 mg Subcutaneous Maintenance Dosing Could Offer a New Option for Ongoing Treatment of Early Alzheimer's Disease</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-30</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.34
                                </span>
                            </div>
                            <div class="article-summary">Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced today that r...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=fc786c739f1a245a5629067131f52d1297f511d6e36f6cac2658a531d853a9a1" target="_blank" rel="noopener noreferrer">Biogen (BIIB) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-30</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Besides Wall Street's top-and-bottom-line estimates for Biogen (BIIB), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quar...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b3906b42bde383ad4b8873d5f06794dbf3dbdc54edacba5b3a54c8373d1acc8f" target="_blank" rel="noopener noreferrer">Two-Year Real-World Study of LEQEMBI® in the United States Presented at Alzheimer's Association International Conference (AAIC) 2025</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-30</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced to...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=ca853c2f00b51b120fb7f12e7919f60abd9141b07c084d2d2a03ce81388630f2" target="_blank" rel="noopener noreferrer">Alkermes: A More Than Solid Quarter</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-30</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.38
                                </span>
                            </div>
                            <div class="article-summary">Alkermes just reported Q2 results, with progress around revenue growth from its product portfolio and some pipeline progress. Click to read why ALKS is a Hold....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=14ab96260f18acd86f46697e21eb78ce601375caa41a872573419c23157d03ae" target="_blank" rel="noopener noreferrer">Sage Therapeutics Announces Second Quarter 2025 Financial Results</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-30</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">CAMBRIDGE, Mass., July 30, 2025--Sage Therapeutics, Inc. (Nasdaq: SAGE), today reported business highlights and financial results for the second quarter ended June 30, 2025....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=6eb26532af4c27d00b0334c5235572d937e7c5eec9835baae2552f5f10afd34f" target="_blank" rel="noopener noreferrer">BioMarin Pharmaceutical (BMRN) Reports Next Week: Wall Street Expects Earnings Growth</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-28</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.37
                                </span>
                            </div>
                            <div class="article-summary">BioMarin (BMRN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=ae60b02c0449d28f4fff96c21b0e1eebd1c463a0d29e887217f207d5b258b2a4" target="_blank" rel="noopener noreferrer">Biogen Gears Up to Report Q2 Earnings: Here's What to Expect</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-28</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.42
                                </span>
                            </div>
                            <div class="article-summary">Biogen's Q2 results may show MS drug declines partially offset by gains from newer drugs....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=62c4a767d17ea9fa389a30852e09a3357654725d5a485cea652900b5d9b1c91a" target="_blank" rel="noopener noreferrer">Biotech stocks dip as Trump administration mulls patent fee overhaul</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-28</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.97
                                </span>
                            </div>
                            <div class="article-summary">Investing.com -- Biotech stocks fell across the board Monday afternoon, with the SPDR S&P Biotech ETF (NYSE:XBI) dropping to a low of 1.1% after reports emerged that the Trump administration is consid...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b6a0ca01de4f17743f40234f04daac481137e86328f8e4d60b67665a385a9e5b" target="_blank" rel="noopener noreferrer">Biogen Gets CHMP Backing for Zurzuvae in Postpartum Depression</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-25</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment positive">
                                    0.81
                                </span>
                            </div>
                            <div class="article-summary">Biogen Gets CHMP Backing for Zurzuvae in Postpartum Depression...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=576a14774364256dc4ea46e4dd1c19d042433c112f22f5854c8dc882446c6bd1" target="_blank" rel="noopener noreferrer">ZURZUVAE® (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-25</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.90
                                </span>
                            </div>
                            <div class="article-summary">CAMBRIDGE, Mass., July 25, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a posi...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=913d5c681ac4ca557bbc571cbf345b03398f44e149139be5b9a57982808628e3" target="_blank" rel="noopener noreferrer">Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-24</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.39
                                </span>
                            </div>
                            <div class="article-summary">Biogen (BIIB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1c99d548a28995bdec00b65219e1cbe57843a112ca316f9afa24f56ca737afe1" target="_blank" rel="noopener noreferrer">Amyotrophic Lateral Sclerosis (ALS) Market Forecast Report 2025-2034 | Advancements in Therapeutics and Approved Medications Such as Riluzole, Edaravone, and Nuedexta Drive Growth</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-23</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.90
                                </span>
                            </div>
                            <div class="article-summary">The ALS treatment market, valued at USD 791.90 Million in 2024, is forecasted to grow at a CAGR of 5.40% from 2025 to 2034. Rising ALS prevalence, demand for treatments, and advancing research propel ...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=392487763cbb441dc3edf9abc1ccbd2a02e692bb902b844834b30cf94f8ac275" target="_blank" rel="noopener noreferrer">Biogen Inc. (BIIB) Partners with Stoke Therapeutics to Tackle Dravet Syndrome</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-22</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.34
                                </span>
                            </div>
                            <div class="article-summary">We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Biogen Inc. stands sixth on our list among the most undervalued stocks. Biogen Inc. (NASDAQ:BIIB) is a global biotechnology leader k...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=7a9ca2b41e22a17139f587bab2d7e352e3b5e8cc659aaebea1b1b5747696153b" target="_blank" rel="noopener noreferrer">Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association International Conference 2025</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-22</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Lecanemab presentations to include long-term Clarity AD data, real-world treatment insights, and a subcutaneous formulation for continued carePresentations on tau to explore its biological role, the d...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b8ce434ea8d09f114aed8f136ae9e26731e47d804fd35f2c8e736d2c5e313ee2" target="_blank" rel="noopener noreferrer">Biogen to invest further $2bn in North Carolina’s Research Triangle Park</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-22</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.70
                                </span>
                            </div>
                            <div class="article-summary">The new investment will support the ongoing development of Biogen's late-stage clinical pipeline....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0266ce23a267f6fc8c51e3bea16c0f3f8971cc13e888716633dc3a976a0fc9e5" target="_blank" rel="noopener noreferrer">Biogen to Invest Additional $2 Billion in North Carolina Research Hub</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-21</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">Biogen to Invest Additional $2 Billion in North Carolina Research Hub...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=309600c6e7f1364dec625a415f7b6ae30fc3d7ed41de0faac8e568f7271fe5e9" target="_blank" rel="noopener noreferrer">Eli Lilly: Competition Melts Away</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-21</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.54
                                </span>
                            </div>
                            <div class="article-summary">Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on my Strong Buy rating for LLY....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=73782963a262645b30a89330afac3633825bbf9e6a88f48c8060bbeca69083f8" target="_blank" rel="noopener noreferrer">Biogen Announces $2 Billion Manufacturing Investment in North Carolina’s Research Triangle Park in Conjunction with its 30th Anniversary</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-21</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.66
                                </span>
                            </div>
                            <div class="article-summary">Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: B...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=938367485f95d02b2dad4104e740a99fbe075f769bb7c30dcf9509fb11612434" target="_blank" rel="noopener noreferrer">Biogen beefs up North Carolina manufacturing ahead of potential drug tariff storm</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-21</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.52
                                </span>
                            </div>
                            <div class="article-summary">Biogen joins major drugmakers such as Eli  Lilly, Roche and Merck, who have all announced investments in the U.S. as the industry braces for potential import levies.  Drugs have so far been exempt fro...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=7aa121e17d80f8a6f5228117c635ea3e46ae3fab696e4323fb201027e46a50c8" target="_blank" rel="noopener noreferrer">Target downgraded, Dollar Tree upgraded: Wall Street's top analyst calls</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-21</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Target downgraded, Dollar Tree upgraded: Wall Street's top analyst calls...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=bbcf22d811b4ae3ca79918fca7152914f40c9ea619da30b2491cc67b39013cdb" target="_blank" rel="noopener noreferrer">S&P 500 and Nasdaq 100 Jump to Record Highs as Bond Yields Fall</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-21</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.74
                                </span>
                            </div>
                            <div class="article-summary">The S&P 500 Index ($SPX ) (SPY ) today is up +0.54%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.41%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.72%. September E-mini S&P futures (...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=8b4506c141a42cf6c49d90105e1d5e82cf0c5497e3d68c40b82c7358a4ee52fb" target="_blank" rel="noopener noreferrer">S&P 500, Nasdaq Scale New Highs in Broad-Based Rally</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-21</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.84
                                </span>
                            </div>
                            <div class="article-summary">US equity indexes advanced in a broad-based rally, with two of the three mainstream indexes hitting...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=280181c4f9719d53d757ae65a3684aa1e84c2d6c46df4ffcd907c6140f078a07" target="_blank" rel="noopener noreferrer">Biogen beefs up North Carolina manufacturing ahead of potential Trump tariff</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-21</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.83
                                </span>
                            </div>
                            <div class="article-summary">Biogen will invest $2 billion more in its existing manufacturing plants in North Carolina, the drugmaker said on Monday, as it seeks to expand in the U.S. amid President Donald Trump's tariff threats....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e3c2208f4e9a02fae52c8ae36a5034d6bf74feac0044713062d9eaa06ad2c69c" target="_blank" rel="noopener noreferrer">Biogen (BIIB) Stock Trades Down, Here Is Why</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-21</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.80
                                </span>
                            </div>
                            <div class="article-summary">Shares of biotech company Biogen (NASDAQ:BIIB) fell 3.1% in the morning session after analysts at Truist downgraded the stock, citing concerns over the company's growth prospects and high-risk pipelin...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f3671c7f3a07cee82a64ae475449a01e859980b9d35f84dbd4738947b78cb331" target="_blank" rel="noopener noreferrer">Here's What to Expect From Biogen's Next Earnings Report</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-18</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.59
                                </span>
                            </div>
                            <div class="article-summary">Biogen is expected to release its fiscal second-quarter earnings later this month, and analysts project a double-digit profit decline....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a79f2aa84b20a7ee359607387f4d7e0522d62c1156ab32fc37c7b11e52672ff1" target="_blank" rel="noopener noreferrer">Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-18</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.58
                                </span>
                            </div>
                            <div class="article-summary">A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like ...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5062ad2118d41e98ac0b6f0ab7e0197b6bde1b0c1cdf74a11f3f48b8ed5d9071" target="_blank" rel="noopener noreferrer">Samsung Bioepis Enters into a Partnership with Harrow for Commercialization of Ophthalmology Biosimilars Portfolio in the United States</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-17</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.73
                                </span>
                            </div>
                            <div class="article-summary">INCHEON, Korea, July 17, 2025--Samsung Bioepis Co., Ltd. ("Samsung Bioepis") announced today that the company has entered into a license, development and commercialization agreement (DCA) with Harrow ...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=bd7c73d9a085d7a907dc288c201c9220699f395b83793b18a2c15d9cc262531c" target="_blank" rel="noopener noreferrer">Harrow Enters into Commercialization Agreement with Samsung Bioepis for Ophthalmology Biosimilars Portfolio in the United States</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-17</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.88
                                </span>
                            </div>
                            <div class="article-summary">NASHVILLE, July 17, 2025--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it has entered into a definitive agreement with Samsung Bioepis Co. Ltd. ...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=293b97a7cae54e8e78b0c149f7e80e6f625aa2938d80e20cd9dd849e83778a39" target="_blank" rel="noopener noreferrer">The drug discovery research for lecanemab awarded the 9th Bioindustry Award by the Japan Bioindustry Association</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-16</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.89
                                </span>
                            </div>
                            <div class="article-summary">BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the drug discovery research for lecanemab (product name Leqembi®), an antibody indicated for early Alzheimer's disea...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=cb0b56daaf668d75e90470e4d439c0e843a6615f148fefabf85074f7ee81ecdc" target="_blank" rel="noopener noreferrer">Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-15</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Douglas E. Williams, Ph.D. Chair of the Board of Directors Strong track record at executive and board level of building company value across all stages of development including supporting the developm...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0285ff261bc9b409d38e02fd93bbec9707a81d2537ef538062e90561e79e5b68" target="_blank" rel="noopener noreferrer">Biogen Inc. stock underperforms Tuesday when compared to competitors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-15</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.90
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock underperforms Tuesday when compared to competitors...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=8a3ebb749ed8432b74e439e74819c73062f0ad18efc354d45d7226c829450eca" target="_blank" rel="noopener noreferrer">Amyotrophic Lateral Sclerosis (ALS) Market Analysis Report 2025-2035 | Increase in Clinical Trials and Investments will Accelerate the Development of Innovative Treatments</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-14</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.75
                                </span>
                            </div>
                            <div class="article-summary">The ALS market is witnessing robust growth driven by increased disease awareness, advancements in genetic research, and an expanding pipeline of therapeutic drugs. ALS, a neurodegenerative disease aff...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=ed6b3e9c41c0c4097ff67891dd2e8c7caf7cf443c0fb78ffe110c1c84137ab35" target="_blank" rel="noopener noreferrer">Why Novartis Is Still A 'Buy' After 15% Surge</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-13</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.37
                                </span>
                            </div>
                            <div class="article-summary">Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks. Find out why NVS stock is a buy....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d865c91a71641dde5c43cd76de6c0a10f08334174afe2cecf528161a1612ab6b" target="_blank" rel="noopener noreferrer">Patient Capital Management Q2 2025 Investment Review</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-13</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">nan...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=2a9deb6742e45552bbbbddc4dc2a16a7bf439ff9790bdabce9967547b739fbfa" target="_blank" rel="noopener noreferrer">Barclays Upgrades Ionis Pharmaceuticals (IONS) Stock, Raises PT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-10</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. Barclays upgraded the company’s stock to “Overweight” from “Equal Weight” wit...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e78da2ce431b58e52329cf08a3b757f34971eafabfed5f3792a78b5720949952" target="_blank" rel="noopener noreferrer">Biogen and Stoke Therapeutics Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) Congress</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-10</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.37
                                </span>
                            </div>
                            <div class="article-summary">– Data from an analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed improvements in cognition and behavior at Week 68 – – These findings support the in...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=4d994501e0e688984803a3cb1ba3bd12f30c5e488b78383ffe1343a5946ff519" target="_blank" rel="noopener noreferrer">Stoke Therapeutics and Biogen Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) Congress</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-10</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">BEDFORD, Mass., & CAMBRIDGE, Mass., July 10, 2025--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RN...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=929f97c6bdcdd4fa431bb3d4412d41a8d45eed1de58551371d292a056251e790" target="_blank" rel="noopener noreferrer">RBC Capital Maintains a Buy on Biogen (BIIB) With a $208 PT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-10</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.52
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. (NASDAQ:BIIB) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. In a report released on July 7, Brian Abrahams from RBC Capital maintained a Buy rating on Biogen Inc. (N...</div>
                        </div>
                    </div>
            
                </div>
            </div>
        </body>
        </html>
        